@article{Luce1996TheVF,
title={The view from managed care pharmacy.},
author={Bryan R. Luce and Chris Lyles and Anne M. Rentz},
journal={Health affairs},
year={1996},
volume={15 4},
pages={
168-76
}
}
This stratified, national telephone survey of fifty-one managed care organizations concerns the perspectives of managed care pharmacy directors on pharmacoeconomics, disease management, and the roles of the pharmaceutical industry and the Food and Drug Administration (FDA). Respondents rated clinical effectiveness assessments as most useful, cost-effectiveness assessments second, and quality-of-life assessments as least useful. Peer-reviewed and industry literature were rated as equally… CONTINUE READING